We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Simulations Plus' Q1 Earnings Lag Estimates, Revenues Surge Y/Y
Read MoreHide Full Article
Simulations Plus, Inc. (SLP - Free Report) reported first-quarter fiscal 2025 adjusted earnings of 17 cents per share, which declined 5.6% year over year. The figure, however, missed the Zacks Consensus Estimate of 18 cents per share.
Quarterly revenues jumped 31% year over year to $18.9 million due to higher Software segment revenues and the acquisition of Pro-ficiency. Continued strength across the company’s core platforms, including GastroPlus, MonolixSuite and ADMET Predictor, was the main catalyst. The Adaptive Learning & Insights (“ALI”) and Medical Communications business units, acquired through the Pro-ficiency buyout in June 2024, contributed $3.7 million in the fiscal first quarter.
It surpassed the Zacks Consensus Estimate by 1.3%. SLP’s organic revenue growth during the quarter was 5%.
Simulations Plus, Inc. Price, Consensus and EPS Surprise
Fiscal first-quarter revenues from Software (57% of total quarterly revenues) rose 41% year over year to $10.7 million, driven by new customer wins and increasing sales with existing customers of GastroPlus, MonolixSuite and ADMET Predictor offerings. GastroPlus, MonolixSuite, ADMET Predictor, ALI and Others contributed 38%, 21%, 12%, 16% and 13%, respectively, to total software revenues. SLP added 12 new customers and had nine upsells in the fiscal first quarter.
The renewal rate for commercial customers was 83% (based upon accounts) and 95% (based on fees) compared with 84% and 100% in the prior quarter, respectively.
Services’ revenues (43%) improved 19% to $8.2 million. On an organic basis, revenues declined 9%, due to the temporary impact of client-driven data delays that deferred the ramp-up of certain projects into the fiscal second quarter.
Quantitative Systems Pharmacology software and Clinical Pharmacology & Pharmacometrics business saw declines of 14% and 6% year over year, respectively. Sales of PBPK unit was down 9%.
Services’ backlog was $17.3 million at the end of the reported quarter, down 8.5% year over year, owing to cost-driven pullback by customers during fiscal 2024.
SLP’s Operating Details
The gross margin in the quarter under review was 54% compared with 62% in the prior-year quarter.
The Software segment’s gross margin was 75% compared with 87% in the prior-year quarter. The margin performance was affected by higher costs related to the amortization of capitalized software development costs from the acquisition of Pro-ficiency.
Services’ gross margin was 26%, down from 36%, owing to lower organic segmental revenues.
Total operating expenses, as a percentage of revenues, were 53% compared with 56% a year ago.
Income from operations was $0.1 million compared with $1 million a year ago. Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) margin was 24%, an increase from 23% in the prior-year quarter.
SLP’s Balance Sheet
As of Nov. 30, 2024, cash and short-term investments were $18.2 million compared with $20.3 million at the end of the prior-year period.
SLP Reiterates Fiscal 2025 Outlook
SLP expects strong momentum in the second half of fiscal 2025.
Simulations Plus expects revenues to be between $90 million and $93 million. This indicates an increase of 28-33% from fiscal 2024 revenues. In addition, the Pro-ficiency acquisition is expected to contribute an additional $15-$18 million to revenues.
The company expects the Software segment mix to be 55-60% of total revenues. SLP estimates adjusted earnings per share to be between $1.07 and $1.20 and adjusted EBITDA margin between 31% and 33%.
BlackBerry (BB - Free Report) reported the third quarter of fiscal 2025 non-GAAP earnings per share (EPS) of 2 cents. The figure was better than the company’s estimate of a loss of 1 cent to EPS of 1 cent. In the year-ago quarter, it reported a non-GAAP EPS of 1 cent. The Zacks Consensus Estimate was pegged at a loss of 2 cents per share. Cost discipline aided the bottom-line performance. Quarterly revenues (including Cylance business, reclassified as held for sale as of Nov. 30, 2024) of $162 million declined 7.4% year over year.
Ciena Corporation (CIEN - Free Report) reported fourth-quarter fiscal 2024 (ended Nov. 2) results, wherein adjusted EPS of 54 cents missed the Zacks Consensus Estimate of 66 cents. Also, the bottom line declined 28% year over year. Quarterly total revenues dipped 0.5% year over year to $1,124.1 million. The top line, however, surpassed the Zacks Consensus Estimate of $1,105 million, driven by robust demand for its solutions in cloud and artificial intelligence (AI)-driven markets. As the demand for bandwidth accelerates, driven by cloud and AI, Ciena is uniquely positioned to unlock opportunities for growth and profitability.
GuidewireSoftware (GWRE - Free Report) reported non-GAAP earnings per share of 43 cents for first-quarter fiscal 2025 (ended Oct. 31, 2024). The figure surpassed the Zacks Consensus Estimate by 43.3%. It reported break-even earnings in the prior-year period. The company reported revenues of $262.9 million, up 27% year over year. Revenues surpassed the Zacks Consensus Estimate by 3.4%. The figure also came ahead of the company’s guided range of $251-$257 million. This uptick was driven by solid deal volume, especially in Tier 1, and increasing international momentum, especially in Asia Pacific and Europe.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
Simulations Plus' Q1 Earnings Lag Estimates, Revenues Surge Y/Y
Simulations Plus, Inc. (SLP - Free Report) reported first-quarter fiscal 2025 adjusted earnings of 17 cents per share, which declined 5.6% year over year. The figure, however, missed the Zacks Consensus Estimate of 18 cents per share.
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
Quarterly revenues jumped 31% year over year to $18.9 million due to higher Software segment revenues and the acquisition of Pro-ficiency. Continued strength across the company’s core platforms, including GastroPlus, MonolixSuite and ADMET Predictor, was the main catalyst. The Adaptive Learning & Insights (“ALI”) and Medical Communications business units, acquired through the Pro-ficiency buyout in June 2024, contributed $3.7 million in the fiscal first quarter.
It surpassed the Zacks Consensus Estimate by 1.3%. SLP’s organic revenue growth during the quarter was 5%.
Simulations Plus, Inc. Price, Consensus and EPS Surprise
Simulations Plus, Inc. price-consensus-eps-surprise-chart | Simulations Plus, Inc. Quote
SLP’s Quarter in Details
Fiscal first-quarter revenues from Software (57% of total quarterly revenues) rose 41% year over year to $10.7 million, driven by new customer wins and increasing sales with existing customers of GastroPlus, MonolixSuite and ADMET Predictor offerings. GastroPlus, MonolixSuite, ADMET Predictor, ALI and Others contributed 38%, 21%, 12%, 16% and 13%, respectively, to total software revenues. SLP added 12 new customers and had nine upsells in the fiscal first quarter.
The renewal rate for commercial customers was 83% (based upon accounts) and 95% (based on fees) compared with 84% and 100% in the prior quarter, respectively.
Services’ revenues (43%) improved 19% to $8.2 million. On an organic basis, revenues declined 9%, due to the temporary impact of client-driven data delays that deferred the ramp-up of certain projects into the fiscal second quarter.
Quantitative Systems Pharmacology software and Clinical Pharmacology & Pharmacometrics business saw declines of 14% and 6% year over year, respectively. Sales of PBPK unit was down 9%.
Services’ backlog was $17.3 million at the end of the reported quarter, down 8.5% year over year, owing to cost-driven pullback by customers during fiscal 2024.
SLP’s Operating Details
The gross margin in the quarter under review was 54% compared with 62% in the prior-year quarter.
The Software segment’s gross margin was 75% compared with 87% in the prior-year quarter. The margin performance was affected by higher costs related to the amortization of capitalized software development costs from the acquisition of Pro-ficiency.
Services’ gross margin was 26%, down from 36%, owing to lower organic segmental revenues.
Total operating expenses, as a percentage of revenues, were 53% compared with 56% a year ago.
Income from operations was $0.1 million compared with $1 million a year ago. Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) margin was 24%, an increase from 23% in the prior-year quarter.
SLP’s Balance Sheet
As of Nov. 30, 2024, cash and short-term investments were $18.2 million compared with $20.3 million at the end of the prior-year period.
SLP Reiterates Fiscal 2025 Outlook
SLP expects strong momentum in the second half of fiscal 2025.
Simulations Plus expects revenues to be between $90 million and $93 million. This indicates an increase of 28-33% from fiscal 2024 revenues. In addition, the Pro-ficiency acquisition is expected to contribute an additional $15-$18 million to revenues.
The company expects the Software segment mix to be 55-60% of total revenues. SLP estimates adjusted earnings per share to be between $1.07 and $1.20 and adjusted EBITDA margin between 31% and 33%.
SLP’s Zacks Rank
Currently, Simulations Plus carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Recent Performance of Other Companies
BlackBerry (BB - Free Report) reported the third quarter of fiscal 2025 non-GAAP earnings per share (EPS) of 2 cents. The figure was better than the company’s estimate of a loss of 1 cent to EPS of 1 cent. In the year-ago quarter, it reported a non-GAAP EPS of 1 cent. The Zacks Consensus Estimate was pegged at a loss of 2 cents per share. Cost discipline aided the bottom-line performance. Quarterly revenues (including Cylance business, reclassified as held for sale as of Nov. 30, 2024) of $162 million declined 7.4% year over year.
Ciena Corporation (CIEN - Free Report) reported fourth-quarter fiscal 2024 (ended Nov. 2) results, wherein adjusted EPS of 54 cents missed the Zacks Consensus Estimate of 66 cents. Also, the bottom line declined 28% year over year. Quarterly total revenues dipped 0.5% year over year to $1,124.1 million. The top line, however, surpassed the Zacks Consensus Estimate of $1,105 million, driven by robust demand for its solutions in cloud and artificial intelligence (AI)-driven markets. As the demand for bandwidth accelerates, driven by cloud and AI, Ciena is uniquely positioned to unlock opportunities for growth and profitability.
Guidewire Software (GWRE - Free Report) reported non-GAAP earnings per share of 43 cents for first-quarter fiscal 2025 (ended Oct. 31, 2024). The figure surpassed the Zacks Consensus Estimate by 43.3%. It reported break-even earnings in the prior-year period. The company reported revenues of $262.9 million, up 27% year over year. Revenues surpassed the Zacks Consensus Estimate by 3.4%. The figure also came ahead of the company’s guided range of $251-$257 million. This uptick was driven by solid deal volume, especially in Tier 1, and increasing international momentum, especially in Asia Pacific and Europe.